Home Watchlists Portfolios Indices Forex Futures Market Scan Chart Settings

Contrasting of Xeris Pharmaceuticals Inc. (XERS) and Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR)



  • Source: Stocks Beat - - Read: 0

    Summary:

     

    Xeris Pharmaceuticals Inc. (NASDAQ:XERS) and Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) compete with each other in the Biotechnology sector. We will analyze and contrast their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation.

    Valuation & Earnings

    Gross Revenue

    Price/Sales Ratio

    Net Income

    Earnings Per Share

    Price/Earnings Ratio

    Xeris Pharmaceuticals Inc.

    11

    149.53

    N/A

    -3.39

    0.00

    Eiger BioPharmaceuticals Inc.

    12

    0.00

    N/A

    -3.84

    0.00

    Demonstrates Xeris Pharmaceuticals Inc. and Eiger BioPharmaceuticals Inc. earnings per share (EPS), top-line revenue and valuation.

    Profitability

    Table 2 shows the return on assets, net margins and return on equity of the two firms.

    Net Margins

    Return on Equity

    Return on Assets

    ...

     

     

    Read Full News: https://stocksbeat.com/2019/08/16/trending-stock-news/contrasting-of-xeris-pharmaceuticals-inc-xers-and-eiger-biopharmaceuticals-inc-nasdaqeigr/


Log in to reply